Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiappetta

Showing results (51-60 of 972) with videos related to

Pageof 98
Sort By:
Hospital Pharmacy|November 4, 2025
Comparative Analysis of Adverse Drug Reactions Between Oritavancin Diphosphate and Oritavancin-HPβCD Using FAERS DataEleonora Castellana, Maria Rachele Chiappetta
Hospital Pharmacy|October 24, 2025
Hospital Pharmacists and the New FDA FAERS Public Dashboard for Cosmetic Products: Expanding Pharmacovigilance into the Cosmetic Safety LandscapeEleonora Castellana, Maria Rachele Chiappetta
Journal of Personality Disorders|June 13, 2012
Subtyping borderline personality disorder by suicidal behaviorPaul H Soloff, Laurel Chiappetta
Journal of Personality Disorders|February 23, 2018
10-Year Outcome of Suicidal Behavior in Borderline Personality DisorderPaul H Soloff, Laurel Chiappetta
Hospital Pharmacy|December 22, 2025
Sublingual Immunotherapy: Insights into Clinical Benefits and Safety ProfileEleonora Castellana, Maria Rachele Chiappetta
European Journal of Hospital Pharmacy : Science and Practice|January 22, 2026
Drug rash with eosinophilia and systemic symptoms: descriptive analysis of pharmacovigilanceEleonora Castellana, Maria Rachele Chiappetta
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|May 4, 2026
Posterior Reversible Encephalopathy Syndrome (PRES) Associated With Lenvatinib: A Disproportionality AnalysisEleonora Castellana, Maria Rachele Chiappetta
Lupus|June 1, 2026
Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosusEleonora Castellana, Maria Rachele Chiappetta
The International Journal of Risk & Safety in Medicine|April 13, 2026
Neuropsychiatric adverse events associated with lorlatinib in ALK-positive NSCLCEleonora Castellana, Maria Rachele Chiappetta
Journal of Neurosurgical Sciences|July 1, 1982
Recurrent massive otorrhagia caused by a petrous carotid aneurysmF Chiappetta, S Vangelista, R Pirrone
Pageof 98

Showing results (51-60 of 972) with videos related to

Sort By:
Pageof 98
Hospital Pharmacy|November 4, 2025
Comparative Analysis of Adverse Drug Reactions Between Oritavancin Diphosphate and Oritavancin-HPβCD Using FAERS DataEleonora Castellana, Maria Rachele Chiappetta
Hospital Pharmacy|October 24, 2025
Hospital Pharmacists and the New FDA FAERS Public Dashboard for Cosmetic Products: Expanding Pharmacovigilance into the Cosmetic Safety LandscapeEleonora Castellana, Maria Rachele Chiappetta
Journal of Personality Disorders|June 13, 2012
Subtyping borderline personality disorder by suicidal behaviorPaul H Soloff, Laurel Chiappetta
Journal of Personality Disorders|February 23, 2018
10-Year Outcome of Suicidal Behavior in Borderline Personality DisorderPaul H Soloff, Laurel Chiappetta
Hospital Pharmacy|December 22, 2025
Sublingual Immunotherapy: Insights into Clinical Benefits and Safety ProfileEleonora Castellana, Maria Rachele Chiappetta
European Journal of Hospital Pharmacy : Science and Practice|January 22, 2026
Drug rash with eosinophilia and systemic symptoms: descriptive analysis of pharmacovigilanceEleonora Castellana, Maria Rachele Chiappetta
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|May 4, 2026
Posterior Reversible Encephalopathy Syndrome (PRES) Associated With Lenvatinib: A Disproportionality AnalysisEleonora Castellana, Maria Rachele Chiappetta
Lupus|June 1, 2026
Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosusEleonora Castellana, Maria Rachele Chiappetta
The International Journal of Risk & Safety in Medicine|April 13, 2026
Neuropsychiatric adverse events associated with lorlatinib in ALK-positive NSCLCEleonora Castellana, Maria Rachele Chiappetta
Journal of Neurosurgical Sciences|July 1, 1982
Recurrent massive otorrhagia caused by a petrous carotid aneurysmF Chiappetta, S Vangelista, R Pirrone
Pageof 98